Is Novocure Stock a Buy?

Cancer is one of the leading causes of death worldwide. That's why dozens of healthcare companies are constantly seeking new ways to treat, diagnose, or prevent it.

Medical device specialist (NASDAQ: NVCR) boasts one of the more innovative approaches to fighting cancer. The company markets wearable devices indicated to treat certain forms of the disease. However, developing innovative products alone isn't enough to make a company's shares a buy.

Does Novocure's overall business justify an investment today? Let's dig in and find out. 

Continue reading

Source Fool.com